Sarah Currie, RNC, MSN, NEA-BC
Senior Vice President and Chief Nursing Executive
Sarah Currie, RNC, MSN, NEA-BC, is a Senior Vice President and Chief Nursing Executive of St. Jude Children’s Research Hospital.
Stories by Sarah Currie
New analytical technique reveals the subtle genetic differences among cancer cells
Sequencing data gives insights into what’s going on in a cell. It’s a lot of information. Read how scientists are finding ways to cut through the information and find causes for disease.
Genetic sequencing: How do we put out the fires of genetically driven cancers?
Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.
Survivorship studies dig in on data
Read how cancer survivorship research reveals more about the late effects of treatment on children – and how the data can paint a more complete picture.
Having those critical conversations about fertility after cancer
As clinicians learn more about the late effects of pediatric cancer treatments, these important discussions with patients are changing.
Research homes in on drug to dampen inflammation fueling life-threatening immune disorder
Researchers have promising information that ruxolitinib may help treat a devastating auto-immune disorder.
On a mission to improve patient care: a course of infection prevention and control
Read about the non-stop efforts to help prevent infection in hospitals around the world: a course of infection prevention and control
Virtual reality: A new way for St. Jude parents to partner in patient family-centered care
Patient family-centered care: Read how this virtual advisory committee will give clinical staff more feedback from cancer patients and families.
Separating fact from fiction using pharmacogenetics
Improving understanding of drugs and how the body reacts to them - - Read how science is improving understanding of genes and medication.
Histiocytic disorders are the focus of annual meeting at St. Jude
Read how clinical experts and researchers are trying to shed some light on histiocytic disorders, which are both extremely rare and difficult to diagnose.
The beginning of the end for the annual flu shot?
Researchers researching a flu vaccine that lasts longer and protects the most vulnerable patients.